Drug Approval | July 02, 2022
Ascentage Pharma gets IND clearance by the US FDA for novel EED Inhibitor APG-5918
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
The compendium was released by Suman Bery, Vice-Chairman, NITI Aayog and Dr. Munjpara Mahendrabhai Kalubhai, Minister of State for Ayush and WCD.
The Government of Quebec, through its agent Investissement Quebec, is granting a loan of CAD 25 million
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
Lacosamide Injection is used to treat partial-onset seizures.
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
The settlement and dismissal resolves all claims between the parties
Condon joins DTx Pharma with more than 20 years of experience in business development, commercial planning, and operations.
Subscribe To Our Newsletter & Stay Updated
